BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Fermé

SecteurImmobilier

32.26 1.96

Résumé

Variation du prix de l'action

24h

Actuel

Min

30.4

Max

32.29

Chiffres clés

By Trading Economics

Revenu

153M

Ventes

951M

P/E

Moyenne du Secteur

148.143

80.437

BPA

0.26

Rendement du dividende

1.26

Marge bénéficiaire

16.106

Employés

6,978

EBITDA

276M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+20.89% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.26%

5.59%

Prochains Résultats

28 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-3.8B

18B

Ouverture précédente

30.3

Clôture précédente

32.26

Sentiment de l'Actualité

By Acuity

61%

39%

166 / 192 Classement par Real estate

Fisher & Paykel Healthcare Corp Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 févr. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 févr. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sept. 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 mai 2024, 00:44 UTC

Market Talk
Résultats

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 mai 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 mai 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 mai 2024, 20:59 UTC

Résultats

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 mai 2024, 20:58 UTC

Résultats

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 mai 2024, 20:57 UTC

Résultats

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 mai 2024, 20:56 UTC

Résultats

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 avr. 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Comparaison

Variation de prix

Fisher & Paykel Healthcare Corp Ltd prévision

Objectif de Prix

By TipRanks

20.89% hausse

Prévisions sur 12 Mois

Moyen 37.453 AUD  20.89%

Haut 42.7 AUD

Bas 35 AUD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

6 ratings

3

Achat

1

Maintien

2

Vente

Sentiment

By Acuity

166 / 192Classement par Immobilier

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.